Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.7K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.1K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scalable Manufacturing of Amino Acid-Based Piezoelectric Biocrystal Films.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

BIOGEN: evidence-grounded multi-agent reasoning framework for transcriptomic interpretation in antimicrobial resistance.

Frontiers in bioinformatics·2026
Same author

Insights Into Dose-Dependent Bone Toxicity Following Partial-Body Exposure to Fractionated Ionizing Radiation In Vivo.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Computational paradigms for antimicrobial resistance prediction: integrating multi-omics, structural modeling, and foundation artificial intelligence systems.

Briefings in bioinformatics·2026
Same author

The Catalytic Activity and Micro-Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Biomedical utility of zinc and copper mediated cerium oxide nanoparticles.

RSC advances·2026

Related Experiment Video

Updated: Sep 5, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level

Mehdi Yazdani-Jahromi1, Niloofar Yousefi1, Aida Tayebi1

  • 1Industrial Engineering and Management Systems, University of Central Florida, Street, 32816, 4000 Central Florida Blvd. Orlando, USA.

Briefings in Bioinformatics
|July 11, 2022
PubMed
Summary
This summary is machine-generated.

We developed AttentionSiteDTI, a deep learning model for predicting drug-target interactions using protein binding sites. This interpretable model shows high accuracy and generalizability, proving effective for drug repurposing.

Keywords:
Binding SitesDTI databaseDTI softwareDeep learningMachine learningSARS-CoV-2Self-Attentiondrug–target interaction

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Related Experiment Videos

Last Updated: Sep 5, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Machine learning

Background:

  • Drug-target interaction (DTI) prediction is crucial for drug discovery.
  • Existing DTI models often lack interpretability and generalizability.
  • Identifying key protein binding sites is essential for accurate DTI prediction.

Purpose of the Study:

  • To introduce AttentionSiteDTI, an interpretable graph-based deep learning model for DTI prediction.
  • To leverage protein binding sites and a self-attention mechanism for enhanced prediction accuracy.
  • To improve model generalizability to new, unseen proteins.

Main Methods:

  • Developed a graph-based deep learning model, AttentionSiteDTI, inspired by Natural Language Processing sentence classification.
  • Utilized protein binding sites and a self-attention mechanism to model drug-target complexes.
  • Evaluated model performance on three benchmark datasets and tested generalizability on new proteins.

Main Results:

  • AttentionSiteDTI achieved superior performance compared to state-of-the-art models on benchmark datasets.
  • The model demonstrated high generalizability, performing well on previously unseen proteins.
  • Computational predictions showed high agreement with experimental validation, highlighting practical potential.

Conclusions:

  • AttentionSiteDTI offers an interpretable and highly generalizable approach to drug-target interaction prediction.
  • The model's ability to identify critical binding sites enhances understanding of drug-target interactions.
  • AttentionSiteDTI shows significant potential as an effective pre-screening tool for drug repurposing applications.